XML 31 R18.htm IDEA: XBRL DOCUMENT v3.26.1
Note 6 - Fair Value
12 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

NOTE 6. FAIR VALUE

 

Securities traded on stock exchanges, or quoted by NASDAQ, are valued according to the NASDAQ Stock Market, Inc. (“NASDAQ”) official closing price, if applicable, or at their last reported sale price as of the close of trading on the New York Stock Exchange (“NYSE”) (normally 4:00 P.M. Eastern Time). If a security is not traded that day, the security will be valued at its most recent bid price.

 

Securities traded in the over-the-counter market, but not quoted by NASDAQ, are valued at the last sale price (or, if the last sale price is not readily available, at the most recent closing bid price as quoted by brokers that make markets in the securities) at the close of trading on the NYSE.

 

Securities traded both in the over-the-counter market and on a stock exchange are valued according to the broadest and most representative market.

 

Securities and other assets that do not have market quotations readily available are valued at their fair value as determined by FCM, as the Board’s valuation designee under SEC rule 2a-5. Those valuations are determined in accordance with the Valuation Procedures used by FCM, subject to oversight by the Board.

 

In pricing illiquid, privately placed securities, FCM, as the valuation designee, is responsible for (1) determining overall valuation guidelines and (2) ensuring that the investments of the Company are valued within the prescribed guidelines.

 

FCM and the Board receive information and recommendations from an independent valuation firm.

 

The values assigned to these investments are based on available information and do not necessarily represent amounts that might ultimately be realized when that investment is sold, as such amounts depend on future circumstances and cannot reasonably be determined until the individual investments are actually liquidated or become readily marketable.

 

APPROACHES TO DETERMINING FAIR VALUE. GAAP. defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). In effect, GAAP applies fair value terminology to all valuations whereas the 1940 Act applies market value terminology to readily marketable assets and fair value terminology to other assets.

 

The main approaches to measuring fair value utilized are the market approach, the income approach, and the asset-based approach. The choice of which approach to use in a particular situation depends on the specific facts and circumstances associated with the company, as well as the purpose for which the valuation analysis is being conducted. Firsthand and the independent valuation firm rely primarily on the market approach. We also considered the income and asset-based approaches in our analysis because certain of the portfolio companies do not have substantial operating earnings relative to the value of their underlying assets.

 

 

-

Market Approach (M): The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. For example, the market approach often uses market multiples derived from a set of comparables. Multiples might lie in ranges with a different multiple for each comparable. The selection of where within the range each appropriate multiple falls requires the use of judgment in considering factors specific to the measurement (qualitative and quantitative).

 

-

Income Approach (I): The income approach uses valuation techniques to convert future amounts (for example, cash flows or earnings) to a single present value amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. Those valuation techniques include present value techniques; option-pricing models, such as the Black-Scholes-Merton formula (a closed-form model) and a binomial model (a lattice model), which incorporate present value techniques; and the multi-period excess earnings method, which is used to measure the fair value of certain assets.

 

-

Asset-Based Approach (A): The asset-based approach examines the value of a company’s assets net of its liabilities to derive a value for the equity holders.

 

FAIR VALUE MEASUREMENT. In accordance with the guidance from the Financial Accounting Standards Board on fair value measurements and disclosures under GAAP, the Company discloses the fair value of its investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements).

 

The guidance establishes three levels of the fair value hierarchy as follows:

 

 

Level 1 -

Unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the date of measurement.

 

Level 2 -

Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument in an inactive market, prices for similar instruments in an active or inactive market, interest rates, prepayment speeds, credit risks, yield curves, default rates, and similar data.

 

Level 3 -

Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Company’s own assumptions about the assumptions a market participant would use in valuing the asset or liability based on the best information available.

 

The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3.

 

The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following is a summary of the inputs used to value the Company’s net assets as of December 31, 2025:

 

ASSETS

 

LEVEL 1
QUOTED PRICES

  

LEVEL 2 OTHER
SIGNIFICANT
OBSERVABLE INPUTS

  

LEVEL 3 SIGNIFICANT
OBSERVABLE INPUTS

 

Common Stocks

            

Advanced Materials

 $  $  $167,642 
Automotive        0 

Total Common Stocks

        167,642 

Preferred Stocks

            
Automotive        0 
Medical Devices        0 
Semiconductor Equipment        0 

Total Preferred Stocks

        0 

Convertible Notes and Non-Convertible Notes

            
Automotive        0 

Medical Devices

        1,523 
Semiconductor Equipment        0 

Total Convertible and Non-Convertible Notes

        1,523 

Investment Companies

  56,271       

Total

 $56,271  $  $169,165 

 

At the end of each calendar quarter, management evaluates the Level 2 and Level 3 assets and liabilities for changes in liquidity, including but not limited to: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and Level 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.

 

The following is a summary of the inputs used to value the Company’s net assets as of December 31, 2024.

 

ASSETS

 

LEVEL 1
QUOTED PRICES

  

LEVEL 2 OTHER
SIGNIFICANT
OBSERVABLE INPUTS

  

LEVEL 3 SIGNIFICANT
OBSERVABLE INPUTS

 

Common Stocks

            

Advanced Materials

 $-  $-  $260,497 
Automotive  -   -   0 
Equipment Leasing  -   -   0 

Total Common Stocks

  -   -   260,497 

Preferred Stocks

            
Automotive  -   -   - 

Equipment Leasing

  -   -   29,466 
Medical Equipment  -   -   0 
Semiconductor Equipment  -   -   0 

Total Preferred Stocks

  -   -   29,466 

Convertible and Non-Convertible Notes

            
Automotive  -   -   0 

Medical Devices

  -   -   25,287 
Semiconductor Equipment  -   -   0 

Total Convertible and Non-Convertible Notes

  -   -   25,287 

Investment Companies

  745,224   -   - 

Total

 $745,224  $-  $315,250 

 

Following is a reconciliation of Level 3 assets (at either the beginning or the ending of the period) for which significant unobservable inputs were used to determine fair value.

 

 

INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS
(LEVEL 3)

 

BALANCE
AS OF 12/31/24

  

NET PURCHASES/
CONVERSIONS

  

NET
SALES/
CONVERSIONS

  

NET
REALIZED GAINS/
(LOSSES)

  

NET
UNREALIZED APPRECIATION (DEPRECIATION)(1)

  

TRANSFERS IN (OUT) OF LEVEL 3

  

BALANCE
AS OF 12/31/25

 

Common Stocks

                            

Advanced Materials

 $260,497  $  $  $  $(92,855) $  $167,642 

Equipment Leasing

           (20,000)  20,000       

Total Common Stocks

  260,497         (20,000)  (72,855)     167,642 

Preferred Stocks

                            

Equipment Leasing

  29,466      (8,623)  (1,921,377)  1,900,534       

Total Preferred Stocks

  29,466      (8,623)  (1,921,377)  1,900,534       

Convertible and Non-Convertible Notes

                            

Automotive

           (24,129,015)  24,129,015       

Medical Devices

  25,287            (23,764)     1,523 

Total Convertible and Non-Convertible Notes

  25,287         (24,129,015)  24,105,251      1,523 

Total

 $315,250  $  $(8,623) $(26,070,392) $25,932,930  $  $169,165 

 

(1)

 

The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of December 31, 2025 was $(116,619).
  

 

Following is a reconciliation of Level 3 assets (at either the beginning or the ending of the period) for which significant unobservable inputs were used to determine fair value as of December 31, 2024.

 

 

INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS
(LEVEL 3)

 

BALANCE
AS OF 12/31/23

  

NET PURCHASES/
CONVERSIONS

  

NET
SALES/
CONVERSIONS

  

NET
REALIZED GAINS/
(LOSSES)

  

NET
UNREALIZED APPRECIATION (DEPRECIATION)(1)

  

TRANSFERS IN (OUT) OF LEVEL 3

  

BALANCE
AS OF 12/31/24

 

Common Stocks

                            

Advanced Materials

 $299,932  $-  $-  $-  $(39,435) $-  $260,497 

Equipment Leasing

  55   -   -   -   (55)  -   - 

Semiconductor Equipment

  -   -   -   -   (3,862,405)  3,862,405   - 

Total Common Stocks

  299,987   -   -   -   (3,901,895)  3,862,405   260,497 

Preferred Stocks

                            

Aerospace

  -   2,441   (156,405)  (11,083,138)  11,237,102   -   - 

Equipment Leasing

  110,172   -   (20,000)  -   (60,706)  -   29,466 

Total Preferred Stocks

  110,172   2,441   (176,405)  (11,083,138)  11,176,396   -   29,466 

Convertible and Non-Convertible Notes

                            

Advanced Materials

  100,000   -   (100,000)  -   -   -   - 

Aerospace

  4,200,000   -   (5,956,261)  (603,530)  2,359,791   -   - 

Automotive

  -   -   (40,000)  -   40,000   -   - 

Medical Devices

  87,713   -   -   -   (62,426)  -   25,287 

Total Convertible and Non-Convertible Notes

  4,387,713   -   (6,096,261)  (603,530)  2,337,365   -   25,287 

Total

 $4,797,872  $2,441  $(6,272,666) $(11,686,668) $9,611,866  $3,862,405  $315,250 

 

(1)

The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of December 31, 2024 was $9,611,866.

 

 

 

The table below represents quantitative disclosure about significant unobservable inputs for Level 3 fair value measurements at December 31, 2025:

 

 

FAIR
VALUE AT
12/31/25

VALUATION TECHNIQUES(1)

UNOBSERVABLE INPUTS

RANGE
(WEIGHTED AVG.)(2)

Direct venture capital investments: Advanced Materials$0.2M

Market Comparable Companies 

Option Pricing Model

 Revenue Multiple(3) 

 Years to Maturity(3)

 Volatility(3)

 Risk-Free Rate(3)

 Discount for Lack of Marketability(4)

0.8x – 0.9x (0.9x)

5 years (5 years)

 50.0% (50%)

3.73% (3.73%)

22.8% (22.8%)

     

Direct venture capital investments: Automotive

$0.0M

Liquidation Value

 Market Value of Invested Capital(3)

$0 ($0)

Direct venture capital investments: Medical Devices

$0.0M

Market Comparable Companies

Market Comparable Transactions

 Revenue Multiple(3) 

 Risk Free Rate(3)

 Going Concern Probability(2)

 Volatility(3) 

0.4x – 0.5x (0.5x)

3.55% (3.55%)

5% (5%)

55% (55%)

Direct venture capital investments: Semiconductor Equipment

$0.0MRecent Transactions Equity Proceeds from Private Transactions(3)  $0 ($0)

 

(1)

There were no changes to the valuation techniques applied between December 31, 2024 and December 31, 2025.

(2)

Weighted average is calculated by weighing the significant unobservable input by the relative fair value of each investment in the category.

(3)

An increase in the input would result in an increase in the securitys valuation; a decrease in the input would result in a decrease in the securitys valuation.

(4)

An increase in the inputs would result in a decrease in the securities valuation; a decrease in the input would result in an increase in the security's valuation.

 

Changes in any of our unobservable inputs, individually, may change the fair value of certain of the Company’s investments.

 

Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Additionally, the fair value of the Company’s investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it.

 

In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned. The below chart represents quantitative disclosure about significant unobservable inputs for Level 3 fair value measurements at December 31, 2024:

 

 

 

FAIR
VALUE AT
12/31/24

VALUATION TECHNIQUES(1)

UNOBSERVABLE INPUTS

RANGE
(WEIGHTED AVG.)(2)

Direct venture capital investments: Advanced Materials

$0.3M

Market Comparable Companies 

Option Pricing Model

Revenue Multiple(3) 

Years to Maturity(3)

Volatility(3)

Risk-Free Rate(3)

Discount for Lack of   Marketability(4)

0.8x – 1.0x (1.0x)

5 years (5 years)

50.0% (50%)

4.38% (4.38%)

22.8% (22.8%)

     

Direct venture capital investments: Automotive

$0.0M

Liquidation Value

Market Value of Invested Capital(3)

$0 ($0)

Direct venture capital investments: Equipment Leasing

$0.0M

Cash Value

Option Pricing Model

Years to Maturity(3) 

Volatility(3) 

Risk-Free Rate(3) 

5 years (5 years)

50.0% (50.0%)

4.38% (4.38%)

Direct venture capital investments: Medical Devices

$0.0M

Market Comparable Companies

Market Comparable Transactions

Revenue Multiple(3) 

Risk Free Rate(3)

Going Concern Probability(2)

Volatility(3) 

0.7x – 1.1x (0.9x)

4.27% (4.27%)

10% (10%)

55% (55%)

Direct venture capital investments: Semiconductor Equipment

$0.0M

Recent Transactions

Equity Proceeds from Private Transactions(3)  

$0 ($0)

 

 

(1)    There were no changes to the valuation techniques applied between December 31, 2024 and December 31, 2025.

 

(2)

Weighted average is calculated by weighing the significant unobservable input by the relative fair value of each investment in the category.

(3)

An increase in the input would result in an increase in the securitys valuation; a decrease in the input would result in a decrease in the securitys valuation.

(4)

An increase in the inputs would result in a decrease in the securities valuation; a decrease in the input would result in an increase in the security's valuation.